The fundraising comes after clinical results showed its system met safety goals and led to metabolic improvements in HbA1c, fasting glucose levels and body weight.
- Home |
- Endogenex nets $50M to carry intestinal diabetes procedure to the FDA
Endogenex nets $50M to carry intestinal diabetes procedure to the FDA
- March 25, 2026
Recent Posts
- Oil jumps 5% as Hormuz tanker attacks escalate, US Gulf hurricane shuts in production
- Crescent Energy to acquire Eagle Ford assets from Devon for $4.2 billion
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
